statistiche ricercatore

Continente	#
AS - Asia	529
EU - Europa	403
NA - Nord America	370
SA - Sud America	57
AF - Africa	17
OC - Oceania	4
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.381

Nazione	#
US - Stati Uniti d'America	336
CN - Cina	183
SG - Singapore	170
IT - Italia	132
DE - Germania	104
HK - Hong Kong	50
BR - Brasile	43
VN - Vietnam	40
NL - Olanda	34
RU - Federazione Russa	29
CA - Canada	27
FR - Francia	25
IN - India	21
FI - Finlandia	19
GB - Regno Unito	17
JP - Giappone	12
KR - Corea	12
ES - Italia	10
AR - Argentina	7
BD - Bangladesh	7
SE - Svezia	7
TR - Turchia	7
DK - Danimarca	5
AT - Austria	4
AU - Australia	4
CI - Costa d'Avorio	4
ID - Indonesia	4
IE - Irlanda	4
PL - Polonia	4
ZA - Sudafrica	4
BE - Belgio	3
CO - Colombia	3
IQ - Iraq	3
MA - Marocco	3
TW - Taiwan	3
UZ - Uzbekistan	3
EG - Egitto	2
GR - Grecia	2
MX - Messico	2
MY - Malesia	2
NP - Nepal	2
PH - Filippine	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
CL - Cile	1
CR - Costa Rica	1
CY - Cipro	1
GF - Guiana Francese	1
HR - Croazia	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
KH - Cambogia	1
KZ - Kazakistan	1
LT - Lituania	1
OM - Oman	1
PA - Panama	1
PK - Pakistan	1
PR - Porto Rico	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SX - ???statistics.table.value.countryCode.SX???	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
VE - Venezuela	1
ZM - Zambia	1
Totale	1.381

Nome	#
Locus for severity implicates CNS resilience in progression of multiple sclerosis	219
ADVANCED AAV-MEDIATED LIVER-DIRECTED GENE THERAPIES FOR HAEMOPHILIA A AND MUCOPOLYSACCHARIDOSIS TYPE VI	178
Intrinsic-Dimension Analysis for Guiding Dimensionality Reduction in Multi-Omics Data	175
Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation	161
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study	160
A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis Susceptibility	134
Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients	112
Involvement of NINJ2 protein in inflammation and blood–brain barrier transmigration of monocytes in multiple sclerosis	86
Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab	73
Genetic mapping across autoimmune diseases reveals shared associations and mechanisms	65
Cripto shapes macrophage plasticity and restricts EndMT in injured and diseased skeletal muscle	57
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease	6
Totale	1.426

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	44	0	0	0	0	0	0	0	0	33	2	7	2
2023/2024	95	3	2	2	6	12	3	11	1	5	15	17	18
2024/2025	425	16	28	15	25	15	29	42	38	30	46	54	87
2025/2026	862	83	120	152	107	78	31	83	43	62	53	50	0
Totale													1.426

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca